Rep. Mike Gallagher

Protection of Women and Girls in Sports Act of 2021 This bill makes it a violation of federal law for a recipient of federal funds who operates, sponsors, or facilitates athletic programs or activities to permit a person whose sex is male to participate in an athletic program or activity that is designated for women or girls. The bill specifies that sex shall be recognized based solely on a person's reproductive biology and genetics at birth.

Maddy summaryThis symbolic resolution designates July 20, 2022, as "Glioblastoma Awareness Day" to highlight the challenges of glioblastoma, a devastating brain cancer with a very poor survival rate (median survival of 8 months). It encourages public awareness, honors individuals affected by the disease, and supports research efforts like the Glioblastoma Therapeutics Network. The resolution does not create new laws or allocate funds but serves as a formal statement to elevate attention on this aggressive cancer.

Ensuring Lasting Smiles Act This bill requires private health insurance plans to cover diagnosis and treatment of congenital anomalies and birth defects, such as reconstructive services and items. Coverage must include services and items that functionally improve, repair, or restore any body part that is medically necessary for normal bodily functions or appearance, as determined by the treating physician. Coverage limits and cost-sharing requirements for such services and items may not be more restrictive than those applicable to all medical and surgical benefits under the plan.

Supply Chain Disruptions Relief Act This bill modifies the treatment of liquidations of new motor vehicle inventory as qualified LIFO (last in first out accounting method) inventory. It allows new motor vehicle dealers to elect to wait until the end of 2025 to replace their inventory for purposes of determining income attributable to the sale of such inventory during 2020 and 2021.

Responsible, Better Understanding of Infrastructure Leveraged Dollars Act or the Responsible BUILD Act This bill establishes the Office of the Special Inspector General for Infrastructure Projects within the Department of Transportation (DOT). Specifically, the office shall provide for independent and objective (1) supervision of certain infrastructure projects; and (2) leadership and coordination of, and recommendations on, policies designed to promote efficiency and effectiveness and to prevent and detect waste, fraud, and abuse related to such projects. The office must submit quarterly reports to Congress and DOT on state spending of infrastructure funding.

Strengthening Supply Chains Through Truck Driver Incentives Act of 2022 This bill allows certain licensed commercial truck drivers a $7,500 tax credit in a taxable year. The adjusted gross income of such drivers may not exceed $90,000 ($135,000 in the case of a joint tax return and $112,500 for heads of household). Such drivers must have driven a truck in a trade or business for a specified number of hours in a taxable year. The credit expires after December 31, 2023.

Protecting o ur Pharmaceutical Supply Chain from China Act of 2022 This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing ingredients manufactured in China, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives. The Food and Drug Administration shall maintain (1) a list of foreign-sourced drugs and active ingredients that are critical for consumer health and safety, and (2) another list identifying such drugs that are produced exclusively in China or use ingredients produced in China. The bill phases in a restriction on federal health care programs purchasing drugs with active ingredients manufactured in China. By January 1, 2024, such programs may not purchase a drug with any active ingredients from China. The Department of Health and Human Services may issue a waiver for an agency or program that is unable to meet this requirement, but no waiver may apply to drugs purchased in or after 2026. Each drug must have labeling listing the country of origin of each active ingredient, and a drug without this labeling shall be deemed misbranded. The bill allows 100% tax expensing for qualified pharmaceutical and medical device manufacturing property placed in service between 2020 and 2026.

Returning Amtrak To Economic Sustainability Act or the RATES Act This bill revises the mission and goals of Amtrak. It encourages an economically sustainable intercity and commuter passenger rail system and requires Amtrak to ensure route profitability proportional to the federal share of investment.

Medical Supply Chain Security Act This bill requires manufacturers of essential medical devices (i.e., those that are life supporting, life-sustaining, or intended for use for a debilitating disease or condition) to notify the Food and Drug Administration (FDA) if the device is discontinued or if there is any meaningful disruption to the device's manufacturing. The bill also authorizes the FDA to expedite review of such a device to mitigate or prevent a shortage. The bill also requires the manufacturer of an essential medical device or drug to report annually to the FDA certain information, such as details about all locations of production and the sourcing of component parts or active pharmaceutical ingredients.

This resolution expresses support for the designation of Welcome Home Vietnam Veterans Day. It also honors and recognizes the contributions of veterans who served in Vietnam.